Header Logo

Connection

David Moore to Adult

Back to Details
This is a "connection" page, showing publications David Moore has written about Adult.
David Moore
Connection Strength
2,507
Adult
  1. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study. Arch Clin Neuropsychol. 2021 Feb 12; 36(2):151-164.
    View in: PubMed
    Score: 0,088
  2. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 02; 27(1):160-167.
    View in: PubMed
    Score: 0,087
  3. Felt Age Discrepancy Differs by HIV Serostatus: A Secondary Analysis. J Assoc Nurses AIDS Care. 2020 Sep-Oct; 31(5):587-597.
    View in: PubMed
    Score: 0,085
  4. Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr. 2020 08 15; 84(5):522-526.
    View in: PubMed
    Score: 0,085
  5. Cumulative Burden of Depression and Neurocognitive Decline Among Persons With HIV: A Longitudinal Study. J Acquir Immune Defic Syndr. 2020 07 01; 84(3):304-312.
    View in: PubMed
    Score: 0,084
  6. Tailoring a mobile health text-messaging intervention to promote antiretroviral therapy adherence among African Americans: A qualitative study. PLoS One. 2020; 15(6):e0233217.
    View in: PubMed
    Score: 0,083
  7. Health need assessment in an indigenous high-altitude population living on an island in Lake Titicaca, Perú. Int J Equity Health. 2019 06 18; 18(1):94.
    View in: PubMed
    Score: 0,078
  8. Outcomes of Psychoeducation and a Text Messaging Adherence Intervention Among Individuals With Hypertension and Bipolar Disorder. Psychiatr Serv. 2019 07 01; 70(7):608-612.
    View in: PubMed
    Score: 0,077
  9. Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):15-23.
    View in: PubMed
    Score: 0,076
  10. Psychosocial Correlates of Frailty Among HIV-Infected and HIV-Uninfected Adults. Behav Med. 2019 Jul-Sep; 45(3):210-220.
    View in: PubMed
    Score: 0,075
  11. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis. 2018 05 02; 66(10):1566-1572.
    View in: PubMed
    Score: 0,072
  12. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res. 2017 Aug; 41(8):1518-1525.
    View in: PubMed
    Score: 0,068
  13. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 Jan 28; 29(3):323-30.
    View in: PubMed
    Score: 0,058
  14. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PLoS One. 2012; 7(11):e47310.
    View in: PubMed
    Score: 0,049
  15. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012 Nov; 16(8):2257-66.
    View in: PubMed
    Score: 0,049
  16. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012; 24(12):1504-13.
    View in: PubMed
    Score: 0,048
  17. Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 Feb; 17(1):50-7.
    View in: PubMed
    Score: 0,043
  18. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007 Mar 30; 21(6):713-9.
    View in: PubMed
    Score: 0,033
  19. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS. 2006 Apr 04; 20(6):879-87.
    View in: PubMed
    Score: 0,031
  20. Determinants of health status and the influence of primary health care services in Latin America, 1990-98. Int J Health Plann Manage. 2003 Oct-Dec; 18(4):279-92.
    View in: PubMed
    Score: 0,026
  21. The Epidemiology and Burden of Childhood Chronic Pancreatitis in South Australia. J Pediatr. 2022 03; 242:93-98.e1.
    View in: PubMed
    Score: 0,023
  22. Multimorbidity networks associated with frailty among middle-aged and older people with HIV. AIDS. 2021 12 01; 35(15):2451-2461.
    View in: PubMed
    Score: 0,023
  23. Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States. Clin Infect Dis. 2021 10 05; 73(7):1149-1156.
    View in: PubMed
    Score: 0,023
  24. Low CD4+ cell count nadir exacerbates the impacts of APOE e4 on functional connectivity and memory in adults with HIV. AIDS. 2021 04 01; 35(5):727-736.
    View in: PubMed
    Score: 0,022
  25. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment. Ophthalmology. 2021 08; 128(8):1209-1221.
    View in: PubMed
    Score: 0,022
  26. Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020 11 01; 34(13):1907-1914.
    View in: PubMed
    Score: 0,021
  27. Outcomes for children after second liver transplantations are similar to those after first transplantations: a binational registry analysis. Med J Aust. 2020 11; 213(10):464-470.
    View in: PubMed
    Score: 0,021
  28. Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances. J Neurovirol. 2020 12; 26(6):888-898.
    View in: PubMed
    Score: 0,021
  29. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Harm Reduct J. 2020 06 11; 17(1):41.
    View in: PubMed
    Score: 0,021
  30. Frailty and Neurocognitive Impairment: Impacts on Quality of Life in HIV. J Assoc Nurses AIDS Care. 2020 May-Jun; 31(3):290-300.
    View in: PubMed
    Score: 0,021
  31. Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. J Acquir Immune Defic Syndr. 2020 03 01; 83(3):251-259.
    View in: PubMed
    Score: 0,020
  32. Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 12 01; 33(15):2309-2316.
    View in: PubMed
    Score: 0,020
  33. Characteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners. Medicine (Baltimore). 2019 Dec; 98(50):e18232.
    View in: PubMed
    Score: 0,020
  34. Risk of developing cerebral ß-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 11 15; 33(14):2157-2166.
    View in: PubMed
    Score: 0,020
  35. Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy. Curr Med Res Opin. 2019 11; 35(11):1955-1963.
    View in: PubMed
    Score: 0,020
  36. Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2019 06 01; 81(2):166-174.
    View in: PubMed
    Score: 0,019
  37. Congenital Rubella Syndrome Surveillance in South Africa Using a Sentinel Site Approach: A Cross-sectional Study. Clin Infect Dis. 2019 05 02; 68(10):1658-1664.
    View in: PubMed
    Score: 0,019
  38. Metabolic Syndrome and Neurocognitive Deficits in HIV Infection. J Acquir Immune Defic Syndr. 2019 05 01; 81(1):95-101.
    View in: PubMed
    Score: 0,019
  39. Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors. J Affect Disord. 2019 05 15; 251:1-7.
    View in: PubMed
    Score: 0,019
  40. Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):e9-e13.
    View in: PubMed
    Score: 0,019
  41. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019 03; 19(3):e77-e88.
    View in: PubMed
    Score: 0,019
  42. Sex differences in HIV-associated cognitive impairment. AIDS. 2018 11 28; 32(18):2719-2726.
    View in: PubMed
    Score: 0,019
  43. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 09 10; 32(14):2005-2015.
    View in: PubMed
    Score: 0,018
  44. Impact of time perspectives on texting intervention to reduce HIV/STI transmission among female sex workers in Tijuana and Ciudad Juarez, Mexico. J Behav Med. 2019 02; 42(1):111-127.
    View in: PubMed
    Score: 0,018
  45. Neurocognitive functioning predicts frailty index in HIV. Neurology. 2018 07 10; 91(2):e162-e170.
    View in: PubMed
    Score: 0,018
  46. Patient Responses on Quality of Care and Satisfaction with Staff After Integrated HIV Care in South African Primary Health Care Clinics. J Assoc Nurses AIDS Care. 2018 Sep - Oct; 29(5):698-711.
    View in: PubMed
    Score: 0,018
  47. A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults. AIDS Behav. 2018 May; 22(5):1562-1572.
    View in: PubMed
    Score: 0,018
  48. Integrated HIV-Care Into Primary Health Care Clinics and the Influence on Diabetes and Hypertension Care: An Interrupted Time Series Analysis in Free State, South Africa Over 4 Years. J Acquir Immune Defic Syndr. 2018 04 15; 77(5):476-483.
    View in: PubMed
    Score: 0,018
  49. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 04 24; 31(7):973-979.
    View in: PubMed
    Score: 0,017
  50. Sexual HIV risk among gay, bisexual and queer transgender men: findings from interviews in Vancouver, Canada. Cult Health Sex. 2017 Nov; 19(11):1197-1209.
    View in: PubMed
    Score: 0,017
  51. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2017 03 27; 31(6):787-795.
    View in: PubMed
    Score: 0,017
  52. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect Dis. 2017 02 27; 17(1):174.
    View in: PubMed
    Score: 0,017
  53. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141.
    View in: PubMed
    Score: 0,017
  54. 'People say that we are already dead much as we can still walk': a qualitative investigation of community and couples' understanding of HIV serodiscordance in rural Uganda. BMC Infect Dis. 2016 11 10; 16(1):665.
    View in: PubMed
    Score: 0,016
  55. Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis. Sci Rep. 2016 09 06; 6:32947.
    View in: PubMed
    Score: 0,016
  56. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis. 2016 Sep 01; 63(5):694-702.
    View in: PubMed
    Score: 0,016
  57. Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2016 Apr 15; 71(5):551-7.
    View in: PubMed
    Score: 0,016
  58. Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS. 2016 Mar 27; 30(6):839-48.
    View in: PubMed
    Score: 0,016
  59. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013. Glob Heart. 2017 12; 12(4):315-322.e3.
    View in: PubMed
    Score: 0,016
  60. Gay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada. J Int AIDS Soc. 2015; 18:20039.
    View in: PubMed
    Score: 0,015
  61. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 Jul 31; 29(12):1483-91.
    View in: PubMed
    Score: 0,015
  62. Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. PLoS One. 2015; 10(4):e0126099.
    View in: PubMed
    Score: 0,015
  63. UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment. Schizophr Res. 2015 May; 164(1-3):187-92.
    View in: PubMed
    Score: 0,015
  64. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016 Apr; 23(6):636-48.
    View in: PubMed
    Score: 0,014
  65. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014; 26(12):1477-81.
    View in: PubMed
    Score: 0,014
  66. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 Jun 01; 28(9):1297-306.
    View in: PubMed
    Score: 0,014
  67. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients. Clin Infect Dis. 2014 Jul 15; 59(2):287-97.
    View in: PubMed
    Score: 0,014
  68. Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort. Int J Epidemiol. 2015 Feb; 44(1):58-67.
    View in: PubMed
    Score: 0,014
  69. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):190-7.
    View in: PubMed
    Score: 0,013
  70. Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol. 2013 Dec; 19(6):565-73.
    View in: PubMed
    Score: 0,013
  71. Allele-dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis. Arthritis Rheum. 2013 Oct; 65(10):2555-61.
    View in: PubMed
    Score: 0,013
  72. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol. 2013 Oct; 19(5):410-7.
    View in: PubMed
    Score: 0,013
  73. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013 Jul-Aug; 7(4):255-63.
    View in: PubMed
    Score: 0,013
  74. The resurgence of tuberculosis and the implications for primary care. Br J Gen Pract. 2013 Jul; 63(612):344-5.
    View in: PubMed
    Score: 0,013
  75. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr. 2013 Apr 15; 62(5):487-95.
    View in: PubMed
    Score: 0,013
  76. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013 Jan 22; 80(4):371-9.
    View in: PubMed
    Score: 0,012
  77. Cerebral ß-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS. 2012 Nov 28; 26(18):2327-35.
    View in: PubMed
    Score: 0,012
  78. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS. 2012 Jul; 26(7):388-94.
    View in: PubMed
    Score: 0,012
  79. HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder. J Clin Exp Neuropsychol. 2012; 34(7):773-81.
    View in: PubMed
    Score: 0,012
  80. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend. 2012 Sep 01; 125(1-2):146-53.
    View in: PubMed
    Score: 0,012
  81. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012 May; 54(10):1485-94.
    View in: PubMed
    Score: 0,012
  82. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/µL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012 Apr; 54(8):1204-11.
    View in: PubMed
    Score: 0,012
  83. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884.
    View in: PubMed
    Score: 0,012
  84. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):371-9.
    View in: PubMed
    Score: 0,011
  85. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS. 2011 Jun 19; 25(10):1317-27.
    View in: PubMed
    Score: 0,011
  86. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses. 2012 Jan; 28(1):95-9.
    View in: PubMed
    Score: 0,011
  87. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr. 2010 Dec; 55(4):451-9.
    View in: PubMed
    Score: 0,011
  88. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):28-35.
    View in: PubMed
    Score: 0,010
  89. Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda. J Int Assoc Physicians AIDS Care (Chic). 2009 Mar-Apr; 8(2):128-38.
    View in: PubMed
    Score: 0,010
  90. Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One. 2009; 4(1):e4149.
    View in: PubMed
    Score: 0,009
  91. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav. 2010 Aug; 14(4):816-23.
    View in: PubMed
    Score: 0,009
  92. Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS. 2008 Oct; 22(10):787-95.
    View in: PubMed
    Score: 0,009
  93. Crypt fission peaks early during infancy and crypt hyperplasia broadly peaks during infancy and childhood in the small intestine of humans. J Pediatr Gastroenterol Nutr. 2008 Aug; 47(2):153-7.
    View in: PubMed
    Score: 0,009
  94. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008 Mar 01; 371(9614):752-9.
    View in: PubMed
    Score: 0,009
  95. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2008 Mar 01; 47(3):304-11.
    View in: PubMed
    Score: 0,009
  96. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007 Mar 30; 21(6):685-92.
    View in: PubMed
    Score: 0,008
  97. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. AIDS. 2006 May 12; 20(8):1117-23.
    View in: PubMed
    Score: 0,008
  98. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS. 2005 Mar 04; 19(4):407-11.
    View in: PubMed
    Score: 0,007
  99. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May; 10(3):317-31.
    View in: PubMed
    Score: 0,007
  100. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12.
    View in: PubMed
    Score: 0,007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.